The Global Market for High Throughput Screening (HTS) is Projected to Exceed US$22.5 Billion by 2022

Critical Importance of Result-Oriented & Expedited Screening in Drug Discovery Programs Drive Growth in the Global High Throughput Screening (HTS) Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global High Throughput Screening (HTS) market. The global market for High Throughput Screening (HTS) is projected to exceed US$22.5 billion by 2022, driven by critical importance of advanced screening technologies in drug discovery programs, visible shift towards high throughput research, and rising investments on high-tech laboratory equipment in public and private R&D projects.

High throughput screening (HTS), a scientific experimentation technique used primarily in drug discovery programs, made a rapid progress over the past two decades to emerge as an innovative multi-disciplinary branch within the broader laboratory technologies domain. Extending a full-fledged laboratory screening platform, HTS facilitates sampling a large number of compounds against vast number of targets in a specified time, to generate more hits, and subsequently more lead compounds, and eventually more new drugs. HTS is actively being utilized in various technology formats including cell-based assay, label-free, lab-on-a-chip, and bioinformatics, each of which require specialized techniques for arriving at desired results. Cell-based HTS has already established its proficiency in early-stage drug discovery programs, and about 55-60% of assays currently being used for target validation in drug discovery are based on cell-based HTS model. With technology-driven approach in modern laboratories becoming reliable, robust and sensitive, adoption of cell-based HTS model has emerged as a natural choice in drug discovery applications. In line with growing adoption of HTS technologies, demand for various HTS instruments, consumables/reagents, and software as well as services is exhibiting faster growth.

Going forward, soaring importance of expedited and result-oriented screening in drug discovery processes including target identification and primary screening is poised to aid HTS market growth. Higher investments on sophisticated R&D solutions in pharmaceutical, biotechnology, CRO, and academic & government R&D domains would especially help HTS market sustain the momentum. Progressive advancements being made in microplate handling systems, liquid handling devices and supporting software, are expected to play pivotal role in future growth. Further, growing image of HTS as a utility tool in relatively newer areas such as stem cell research and metabolic activity analysis would infuse fresh opportunities for HTS solutions. At the same time, growing awareness about core benefits offered by HTS platform such as accelerated target interrogation, scaling efficiency, and overall reduced screening costs would steer market growth.

As stated by the new market research report on High Throughput Screening (HTS), the United States represents the largest market worldwide, followed by Europe. Asia-Pacific ranks as the fastest growing market with a CAGR of 9.2% over the analysis period. Increased investments in life sciences research and healthcare infrastructure, especially in clinical diagnostics, in countries such as China, India, South Korea, Taiwan and Indonesia, would propel future growth in the Asia-Pacific region.

Key players in the market include Agilent Technologies Inc., Aurora Biomed Inc., Axxam SpA, BD Biosciences, Beckman Coulter Inc., Bio-Rad Laboratories Inc., BioTek Instruments Inc., BMG LABTECH GmbH, Charles River Laboratories International Inc., Corning Inc., Danaher Corporation, DiscoveRx Corporation, Evotec AG, F. Hoffmann-La Roche Ltd., Genedata AG, IntelliCyt® Corporation, Luminex Corporation, Molecular Devices Inc., Pall ForteBio LLC, PerkinElmer Inc., Sigma-Aldrich Corp., Tecan Group Ltd. and Thermo Fisher Scientific Inc., among others.

The research report titled “High Throughput Screening: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers, issues, mergers, acquisitions, and other strategic industry activities of major players worldwide. The report provides market estimates and projections for all major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America), and Rest of World. Product types analyzed for the global market include Consumables/Reagents, Instruments, and Software & Services. The report also analyses the global market by technology types - Label-Free Technology, Cell-Based Assay, and Others.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.